BiotechTube

tibolone + raloxifen

ApprovedCompleted
0 watching 0 views this week🔥 Hot
80
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Osteopenia

Conditions

Osteopenia

Trial Timeline

Jul 31, 2000 → Feb 15, 2005

NCT ID
NCT00431431

About tibolone + raloxifen

tibolone + raloxifen is a approved stage product being developed by Organon for Osteopenia. The current trial status is completed. This product is registered under clinical trial identifier NCT00431431. Target conditions include Osteopenia.

Hype Score Breakdown

Clinical
30
Activity
20
Company
5
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00431431ApprovedCompleted

Competing Products

18 competing products in Osteopenia

See all competitors
ProductCompanyStageHype Score
Teriparatide + Zoledronic AcidEli LillyApproved
85
alendronate sodiumMerckApproved
85
zoledronic acidNovartisPhase 3
77
zoledronic acid vs pamidronateNovartisApproved
85
Zoledronic Acid + PlaceboNovartisPhase 3
77
BPS804 20mg/Kg + Placebo to 20mg/Kg BPS804NovartisPhase 2
52
Placebo + ibandronate [Bonviva/Boniva]RocheApproved
85
ibandronate [Bonviva/Boniva] + PlaceboRochePhase 3
77
Romosozumab + PlaceboAmgenPhase 1
32
Placebo + AMG 167AmgenPhase 1
32
AMG 167 + PlaceboAmgenPhase 1
32
Romosozumab + PlaceboAmgenPhase 1
32
DenosumabAmgenPhase 3
76
Romosozumab + PlaceboAmgenPhase 1
32
Dasatinib 100 Mg Oral TabletNovo NordiskPhase 2
51
RN564PfizerPhase 1
32
risedronate + alendronateSanofiPhase 1
32
Menostar (Estradiol, BAY86-5435) + RaloxifeneBayerPhase 3
74

Other Products from Organon

desloratadineApproved
80
ezetimibe + statinsApproved
80
losartan potassium + Comparator: carvedilol + Comparator: losartan (+) hydrochlorothiazide (HCTZ) + Comparator: carvedilol (+) hydrochlorothiazideApproved
80
Desloratadine 5 mg + fexofenadineApproved
80
simvastatin (+) ezetimibe + atorvastatinApproved
80